The treatment of liposarcoma in 2026 is moving toward a more localized and aggressive approach, with the global market projected to grow from $1.91 billion in 2025 to nearly $3 billion by 2035. Historically, surgery was the only reliable option for these deep-tissue tumors, but 2026 has seen the rise of intratumoral therapies that are injected directly into the mass to shrink it before the...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
คลิกดาวน์โหลด
thai
English
French
Spanish
Italiano
Romaian
Portuguese (Brazil)
china